Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma

NCT00003632 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
DRUG: carmustine
DRUG: cytarabine
DRUG: etoposide
DRUG: melphalan
DRUG: methotrexate
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]